Ranks stocks by their RS Score — how much each stock's return beats (or lags) the sector average over 1D, 5D, 20D and 60D timeframes. Outperformers = stocks consistently above the sector average.
RS Score = weighted avg of relative returns across all timeframes. Positive = outperforming sector.
6
▲ Outperformers
3
— In-Line
9
▼ Underperformers
18
All Stocks
Filter:×
#
Symbol
LTP
1D
5D
20D
60D
Rel 1D
Rel 5D
Rel 20D
Rel 60D
TF▲
RS Score
RSI
EMA
ST
Status
1
LAURUSLABS
1974.90
+1.67%
+7.33%
+10.50%
+44.28%
+1.38%
+6.71%
+10.45%
+37.14%
+19.47
71.5
▲
▲
▲ Out
2
DIVISLAB
9344.00
-0.75%
+2.68%
+10.23%
+38.08%
-1.04%
+2.06%
+10.18%
+30.94%
+15.74
69.2
▲
▲
▲ Out
3
GRANULES
913.80
+1.93%
+7.72%
+6.45%
+16.84%
+1.64%
+7.10%
+6.40%
+9.70%
+7.38
67.0
▲
▲
▲ Out
4
AUROPHARMA
1675.80
+0.59%
+1.37%
+3.31%
+16.08%
+0.30%
+0.75%
+3.26%
+8.94%
+4.73
61.6
▲
▲
▲ Out
5
GLENMARK
2425.00
+0.91%
-0.50%
+4.60%
+12.58%
+0.62%
-1.12%
+4.55%
+5.44%
+3.38
55.1
▲
▲
▲ Out
6
TORNTPHARM
4963.00
+0.77%
+2.18%
+2.69%
+11.64%
+0.48%
+1.56%
+2.64%
+4.50%
+2.95
55.2
▲
▲
▲ Out
7
LALPATHLAB
1897.00
-0.78%
+1.04%
-1.01%
+14.08%
-1.07%
+0.42%
-1.06%
+6.94%
+2.44
52.9
▲
▲
— In-Line
8
METROPOLIS
583.00
-2.02%
-0.97%
+6.87%
+7.47%
-2.31%
-1.59%
+6.82%
+0.33%
+1.63
60.0
▲
▲
— In-Line
9
APOLLOHOSP
8870.00
-0.27%
+2.54%
-0.57%
+5.45%
-0.56%
+1.92%
-0.62%
-1.69%
-0.53
57.6
▲
▼
▼ Under
10
ZYDUSLIFE
1122.30
+0.34%
+0.21%
-1.14%
+4.46%
+0.05%
-0.41%
-1.19%
-2.68%
-1.51
53.7
▲
▲
▼ Under
#
Symbol
LTP
1D
5D
20D
60D
Rel 1D
Rel 5D
Rel 20D
Rel 60D
TF▲
RS Score
RSI
EMA
ST
Status
1
LAURUSLABS
1974.90
+1.67%
+7.33%
+10.50%
+44.28%
+1.38%
+6.71%
+10.45%
+37.14%
+19.47
71.5
▲
▲
▲ Out
2
DIVISLAB
9344.00
-0.75%
+2.68%
+10.23%
+38.08%
-1.04%
+2.06%
+10.18%
+30.94%
+15.74
69.2
▲
▲
▲ Out
3
GRANULES
913.80
+1.93%
+7.72%
+6.45%
+16.84%
+1.64%
+7.10%
+6.40%
+9.70%
+7.38
67.0
▲
▲
▲ Out
4
AUROPHARMA
1675.80
+0.59%
+1.37%
+3.31%
+16.08%
+0.30%
+0.75%
+3.26%
+8.94%
+4.73
61.6
▲
▲
▲ Out
5
GLENMARK
2425.00
+0.91%
-0.50%
+4.60%
+12.58%
+0.62%
-1.12%
+4.55%
+5.44%
+3.38
55.1
▲
▲
▲ Out
6
TORNTPHARM
4963.00
+0.77%
+2.18%
+2.69%
+11.64%
+0.48%
+1.56%
+2.64%
+4.50%
+2.95
55.2
▲
▲
▲ Out
7
LALPATHLAB
1897.00
-0.78%
+1.04%
-1.01%
+14.08%
-1.07%
+0.42%
-1.06%
+6.94%
+2.44
52.9
▲
▲
— In-Line
8
METROPOLIS
583.00
-2.02%
-0.97%
+6.87%
+7.47%
-2.31%
-1.59%
+6.82%
+0.33%
+1.63
60.0
▲
▲
— In-Line
9
APOLLOHOSP
8870.00
-0.27%
+2.54%
-0.57%
+5.45%
-0.56%
+1.92%
-0.62%
-1.69%
-0.53
57.6
▲
▼
▼ Under
10
ZYDUSLIFE
1122.30
+0.34%
+0.21%
-1.14%
+4.46%
+0.05%
-0.41%
-1.19%
-2.68%
-1.51
53.7
▲
▲
▼ Under
11
SUNPHARMA
1840.90
-0.49%
-3.06%
-4.62%
+0.88%
-0.78%
-3.68%
-4.67%
-6.26%
-4.72
37.2
▼
▲
▼ Under
12
CIPLA
1356.90
-1.24%
-2.03%
-6.42%
+0.10%
-1.53%
-2.65%
-6.47%
-7.04%
-5.44
28.9
▼
▼
▼ Under
13
ABBOTINDIA
25540.00
+1.23%
-2.01%
-5.62%
-2.31%
+0.94%
-2.63%
-5.67%
-9.45%
-5.91
33.1
▼
▼
▼ Under
14
DRREDDY
1173.00
+2.80%
+1.91%
-2.25%
-7.46%
+2.51%
+1.29%
-2.30%
-14.60%
-6.02
43.8
▼
▼
— In-Line
15
ALKEM
5089.50
-0.42%
-1.94%
-5.19%
-5.26%
-0.71%
-2.56%
-5.24%
-12.40%
-7.12
24.2
▼
▼
▼ Under
16
BIOCON
391.75
+0.19%
-1.42%
-6.06%
-5.34%
-0.10%
-2.04%
-6.11%
-12.48%
-7.24
31.7
▼
▼
▼ Under
17
LUPIN
2094.90
+1.01%
-0.72%
-6.27%
-9.98%
+0.72%
-1.34%
-6.32%
-17.12%
-8.94
28.7
▼
▼
▼ Under
18
SYNGENE
383.10
-0.23%
-3.16%
-4.57%
-12.99%
-0.52%
-3.78%
-4.62%
-20.13%
-10.25
35.4
▼
▼
▼ Under
#
Symbol
LTP
1D
5D
20D
60D
Rel 1D
Rel 5D
Rel 20D
Rel 60D
TF▲
RS Score
RSI
EMA
ST
Status
1
LAURUSLABS
1974.90
+1.67%
+7.33%
+10.50%
+44.28%
+1.38%
+6.71%
+10.45%
+37.14%
+19.47
71.5
▲
▲
▲ Out
2
DIVISLAB
9344.00
-0.75%
+2.68%
+10.23%
+38.08%
-1.04%
+2.06%
+10.18%
+30.94%
+15.74
69.2
▲
▲
▲ Out
3
GRANULES
913.80
+1.93%
+7.72%
+6.45%
+16.84%
+1.64%
+7.10%
+6.40%
+9.70%
+7.38
67.0
▲
▲
▲ Out
4
AUROPHARMA
1675.80
+0.59%
+1.37%
+3.31%
+16.08%
+0.30%
+0.75%
+3.26%
+8.94%
+4.73
61.6
▲
▲
▲ Out
5
GLENMARK
2425.00
+0.91%
-0.50%
+4.60%
+12.58%
+0.62%
-1.12%
+4.55%
+5.44%
+3.38
55.1
▲
▲
▲ Out
6
TORNTPHARM
4963.00
+0.77%
+2.18%
+2.69%
+11.64%
+0.48%
+1.56%
+2.64%
+4.50%
+2.95
55.2
▲
▲
▲ Out
#
Symbol
LTP
1D
5D
20D
60D
Rel 1D
Rel 5D
Rel 20D
Rel 60D
TF▲
RS Score
RSI
EMA
ST
Status
1
LALPATHLAB
1897.00
-0.78%
+1.04%
-1.01%
+14.08%
-1.07%
+0.42%
-1.06%
+6.94%
+2.44
52.9
▲
▲
— In-Line
2
METROPOLIS
583.00
-2.02%
-0.97%
+6.87%
+7.47%
-2.31%
-1.59%
+6.82%
+0.33%
+1.63
60.0
▲
▲
— In-Line
3
DRREDDY
1173.00
+2.80%
+1.91%
-2.25%
-7.46%
+2.51%
+1.29%
-2.30%
-14.60%
-6.02
43.8
▼
▼
— In-Line
#
Symbol
LTP
1D
5D
20D
60D
Rel 1D
Rel 5D
Rel 20D
Rel 60D
TF▲
RS Score
RSI
EMA
ST
Status
1
APOLLOHOSP
8870.00
-0.27%
+2.54%
-0.57%
+5.45%
-0.56%
+1.92%
-0.62%
-1.69%
-0.53
57.6
▲
▼
▼ Under
2
ZYDUSLIFE
1122.30
+0.34%
+0.21%
-1.14%
+4.46%
+0.05%
-0.41%
-1.19%
-2.68%
-1.51
53.7
▲
▲
▼ Under
3
SUNPHARMA
1840.90
-0.49%
-3.06%
-4.62%
+0.88%
-0.78%
-3.68%
-4.67%
-6.26%
-4.72
37.2
▼
▲
▼ Under
4
CIPLA
1356.90
-1.24%
-2.03%
-6.42%
+0.10%
-1.53%
-2.65%
-6.47%
-7.04%
-5.44
28.9
▼
▼
▼ Under
5
ABBOTINDIA
25540.00
+1.23%
-2.01%
-5.62%
-2.31%
+0.94%
-2.63%
-5.67%
-9.45%
-5.91
33.1
▼
▼
▼ Under
6
ALKEM
5089.50
-0.42%
-1.94%
-5.19%
-5.26%
-0.71%
-2.56%
-5.24%
-12.40%
-7.12
24.2
▼
▼
▼ Under
7
BIOCON
391.75
+0.19%
-1.42%
-6.06%
-5.34%
-0.10%
-2.04%
-6.11%
-12.48%
-7.24
31.7
▼
▼
▼ Under
8
LUPIN
2094.90
+1.01%
-0.72%
-6.27%
-9.98%
+0.72%
-1.34%
-6.32%
-17.12%
-8.94
28.7
▼
▼
▼ Under
9
SYNGENE
383.10
-0.23%
-3.16%
-4.57%
-12.99%
-0.52%
-3.78%
-4.62%
-20.13%
-10.25
35.4
▼
▼
▼ Under
Live data via NSE/BSE · Auto-refresh every 60s during market hours
What is Relative Outperformance?
Relative outperformance measures how a stock performs compared to its sector peers — not in absolute terms, but relative to what the whole sector is doing. A stock that rises 3% when its sector is up 1% is outperforming by 2%.
Rel 1D / 5D / 20D / 60D: Stock return minus sector average return for that period. Positive = beating the sector. Negative = lagging.
TF▲ dots: 4 dots — one per timeframe (1D, 5D, 20D, 60D). Green dot = outperforming sector on that timeframe.
RS Score: Weighted composite — 60D carries the most weight (40%), followed by 20D (30%), 5D (20%), 1D (10%). Reflects consistent outperformance, not just a one-day spike.
Outperformer: Stock beats the sector average on 3 or more of the 4 timeframes.
Underperformer: Stock beats the sector average on 1 or fewer timeframes.
How to use this screener
Use Outperformers with Bullish EMA + Bullish Supertrend for high-conviction long setups — these stocks are leading their sector and have technical confirmation. Use Underperformers with Bearish signals for short setups or stocks to avoid.
What is Relative Outperformance vs Relative Strength?
Relative Outperformance and Relative Strength are related but different. Relative Strength compares a stock's performance to the broad market index (e.g. Nifty 50). Relative Outperformance compares a stock's performance to its own sector peers — showing how much more (or less) it gained compared to the average stock in its sector.
Columns in the Relative Outperformance Screener
7-day Outperformance: Percentage by which the stock has outperformed or underperformed its benchmark index in the past seven days.
3-month Outperformance: Percentage by which the stock has outperformed or underperformed in the past three months.
Relative Outperformance wrt Index: Shows insights on stocks that outperform in the last 7 days (short and medium term) and last 60 days. Stocks outperforming in recent periods are the best candidates for short-term trades.
FAQs on Relative Outperformance
What is relative performance in the stock market? Relative performance is the return of a stock compared to a benchmark index, sector, or peer group, expressed as a percentage.
What does it mean when a stock is outperforming? An outperforming stock is expected to do better than the market return. Other terms used for this are "moderate buy", "accumulate", or "overweight".
What causes a stock to outperform? Factors such as favourable market conditions, strong company fundamentals, customer loyalty, and industry tailwinds can cause a stock to outperform its peers.
How can you tell if a stock is outperforming the market? If the stock's return is higher than the benchmark return over the same period, it is outperforming.